Nikolaos Kanellias

Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease

Efstathios Kastritis, Evangelos Terpos, Lia A. Moulopoulos et al. · Leukemia · 2012 · 158 citations

Hematological Malignancy, Asymptomatic Myeloma, Health Sciences +12

The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment

Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos et al. · Blood Cancer Journal · 2021 · 126 citations · Full text

Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy

Evangelos Terpos, Efstathios Kastritis, D. Christoulas et al. · Annals of Oncology · 2012 · 109 citations · Full text

Hematological Malignancy, Advanced Multiple Myeloma, Medicine +8

Cardiac and renal complications of carfilzomib in patients with multiple myeloma

Meletios Α. Dimopoulos, Maria Gavriatopoulou, Erasmia Psimenou et al. · Blood Advances · 2017 · 104 citations · Full text

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

Annie Cowan, Federico Ferrari, Samuel S. Freeman et al. · The Lancet Haematology · 2023 · 72 citations · Full text